Epstein Secrets

tial partners (trading +5.8%) • Tieto good O4, cost reductions ahead, sees solid growth, telco to remain tough, strong into #'s (trading +6.1%) • Swatch may be ousted from the SMI after changing to Swiss GAAP accounting rules in October (trading -1.5%) • Aer Lingus FY sales in line, PBT lower, passe

($440M convert), TICC, WNS IPO's (filed/priced): Boise Cascade (BCC) 11.8M shares priced at $21 IPO's (lock-up expires): Manchester United (MANU) US Key Research: ••• JMP upgrades AGN, JPM downgrades TRMB/ACI, Citi upgrades CG/GCI & downgrades SLGN/CNC/MNI • CLSA downgrades DELL & upgrades CHD, Raja downgrad

beat outlook with potential to exceed depending on FX (trading +2.7%) • +0.60%Swiss watch exports -3.0%, 200-500 CHF only segment better = benefits Swatch (UHR +0.60%, CFR -0.20%) • Ladbrokes: Guardian article on potential delay to new gaming machine regulation (trading +0.10%) • Anglo American O2 p

, SNTI IPO's (filed/priced): UCP (UCP) 7.75M-shares priced at $15 (low-end), OncoMed Pharmaceuticals(OMED) 4.8M shares priced at $17 (above range) US Key Research: Stifel initiates Shippers — STNG/NNA/CPLP/TNP/ANW (buys) & DSX/NMM/CMRE (holds) & SSW (sell) ••• Wedbush initiates UA (op), Bernstein initiates FO

ew Air freight model (trading -4.9%) • Ansaldo FY net/div inline, guidance light, Pansa resigns, no Libyan clarity on contracts (trading -1.3%) • Swatch says needs to calm spirits on growth expectations (China slower on less gift-giving) (trading -1.6%) • Eurozone O4 preliminary GDP -0.6% q/q versus

ced): O, DISCA, MTG, ARI, MHO, EDEN FP, DANSKE DC IPO's: Tetraphase Pharmaceuticals (TTPH) pricing 3/19, Enanta Pharmaceuticals (ENTA) pricing 3/20 US Key Research: ••• Berenberg downgrades AAPUCNH/Samsung (sells), Atlantic initiates COV & VAR (ow's) ••• Multiple BFAM initiations, Citi downgrades JCP, GS remov